Mayo Clinic conducts clinical trials to improve the diagnosis
and treatment of bipolar disorder. Mayo is a leader in
pharmacogenomics research, the study of how genetic factors can
predict a person's response to a medication. One focus of Mayo
research is connecting specific genetic profiles with responses
to specific antidepressant drugs used to treat bipolar disorder.
Mayo psychiatrists are working with other specialists to
determine the biological basis of bipolar disorder in children
and to identify better, safer and more-effective treatments for
children and teens. See a list of publications by Mayo Clinic
doctors and researchers on bipolar disorder on PubMed, a service
of the National Library of Medicine.